Protein Kinase G1 α Overexpression Increases Stem Cell Survival and Cardiac Function after Myocardial Infarction

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wang, Linlin ^a   Pasha, Zeeshan ^a   Wang, Shuyun ^a   Li, Ning ^a   Feng, Yuliang ^a   Lu, Gang ^a   Millard, Ronald W ^a   Ashraf, Muhammad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; CASPASE 3; CASPASE 7; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE 3BETA; LACTATE DEHYDROGENASE; PROTEIN BCL 2; PROTEIN KINASE B; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; TROPONIN I;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; CYCLIC GMP DEPENDENT PROTEIN KINASE 1 GENE; ENZYME ACTIVITY; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NICK END LABELING; NONHUMAN; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SRY GENE; TRANSGENE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE I; DISEASE MODELS, ANIMAL; GENE EXPRESSION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

RATTUS;

EID: 84875447538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060087     Document Type: Article

References (46)

1. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, et al. (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156.
2. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, et al. (2009) Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America 106: 14022-14027.
3. Makkar RR, Price MJ, Lill M, Frantzen M, Takizawa K, et al. (2005) Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. Journal of cardiovascular pharmacology and therapeutics 10: 225-233.
4. Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, et al. (2006) Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene therapy 13: 1564-1568.
5. Pasha Z, Wang Y, Shiekh R, Zhang D, Zhao T, Ashraf M, (2008) Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. Jan 1 77(1): 134-42.
6. Chen SL, Fang WW, Ye F, Liu YH, Qian J, et al. (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American journal of cardiology 94: 92-95.
7. Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, et al. (2011) Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circulation research 108: 792-796.
8. Trachtenberg B, Velazquez DL, Williams AR, McNiece I, Fishman J, et al. (2011) Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. American heart journal 161: 487-493.
9. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, et al. (2002) Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. Journal of molecular and cellular cardiology 34: 107-116.
10. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, et al. (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. Journal of molecular and cellular cardiology 33: 907-921.
11. Freyman T, Polin G, Osman H, Crary J, Lu M, et al. (2006) A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European heart journal 27: 1114-1122.
12. Yang YJ, Qian HY, Huang J, Li JJ, Gao RL, et al. (2009) Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arteriosclerosis, thrombosis, and vascular biology 29: 2076-2082.
13. Jiang Y, Chen L, Tang Y, Ma G, Shen C, et al. (2010) HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study. Basic research in cardiology 105: 431-442.
14. Noort WA, Feye D, Van Den Akker F, Stecher D, Chamuleau SA, et al. (2010) Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results. Panminerva medica 52: 27-40.
15. Robey TE, Saiget MK, Reinecke H, Murry CE, (2008) Systems approaches to preventing transplanted cell death in cardiac repair. Journal of molecular and cellular cardiology 45: 567-581.
16. Haider H, Ashraf M, (2008) Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. Journal of molecular and cellular cardiology 45: 554-566.
17. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature biotechnology 25: 1015-1024.
18. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, et al. (2000) Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. The Journal of biological chemistry 275: 21722-21729.
19. Soff GA, Cornwell TL, Cundiff DL, Gately S, Lincoln TM, (1997) Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. The Journal of clinical investigation 100: 2580-2587.
20. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM, (1997) Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. Journal of vascular research 34: 245-259.
21. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, et al. (2003) Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circulation research 92: 308-313.
22. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, De Jonge HR, (1997) Distinct and specific functions of cGMP-dependent protein kinases. Trends in biochemical sciences 22: 307-312.
23. Wollert KC, Fiedler B, Gambaryan S, Smolenski A, Heineke J, et al. (2002) Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension 39: 87-92.
24. Draijer R, Vaandrager AB, Nolte C, de Jonge HR, Walter U, et al. (1995) Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circulation research 77: 897-905.
25. Das A, Smolenski A, Lohmann SM, Kukreja RC, (2006) Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte. The Journal of biological chemistry 281: 38644-38652.
26. Frantz S, Klaiber M, Baba HA, Oberwinkler H, Volker K, et al. (2011) Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I. European heart journal.
27. Das A, Xi L, Kukreja RC, (2008) Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. The Journal of biological chemistry 283: 29572-29585.
28. Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, et al. (2009) Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide. Circulation 120: S31-36.
29. Salloum FN, Abbate A, Das A, Houser JE, Mudrick CA, et al. (2008) Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. American journal of physiology Heart and circulatory physiology 294: H1398-1406.
30. Li L, Haider H, Wang L, Lu G, Ashraf M, (2012) Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarction. American journal of physiology Heart and circulatory physiology 302: H2112-2121.
31. Haider H, Lee YJ, Jiang S, Ahmed RP, Ryon M, et al. (2010) Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells. American journal of physiology Heart and circulatory physiology 299: H1395-1404.
32. Hoke NN, Salloum FN, Kass DA, Das A, Kukreja RC, (2012) Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice. Stem cells 30: 326-335.
33. Feil R, Gappa N, Rutz M, Schlossmann J, Rose CR, et al. (2002) Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase 1 isoforms. Circulation research 90: 1080-1086.
34. Aggarwal S, Rafikov R, Gross CM, Kumar S, Pardo D, et al. (2011) Purification and functional analysis of protein kinase G-1alpha using a bacterial expression system. Protein expression and purification 79: 271-276.
35. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F, (2003) Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circulation research 93: 907-916.
36. Lu G, Haider H, Porollo A, Ashraf M, (2010) Mitochondria-specific transgenic overexpression of connexin-43 simulates preconditioning-induced cytoprotection of stem cells. Cardiovascular research 88: 277-286.
37. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ, (2003) Mesenchymal stem cells modified with Akt prevent remodelling and restore performance of infarcted hearts. Nat. Med 9: 1195-1201.
38. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lützow K, Lendlein A, Stamm C, Li RK, Steinhoff G, (2007) Bcl-2 engineered MSCs inhibited apoptosis and improved heart functions. Stem Cells. 2007 Aug 25(8): 2118-27.
39. Pasha Z, Haider K H, M Ashraf, (2011) Efficient non viral reprogramming of myoblasts to stemness with a single small molecule for generating cardiac progenitors cells. PLoS One 6(8): e23667 Epub 2011 Aug 17.
40. Yang ZJ, Zhang YR, Chen B, Zhang SL, Jia EZ, et al. (2009) Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease. Molecular biology reports 36: 1323-1329.
41. Dong F, Harvey J, Finan A, Weber K, Agarwal U, et al. (2012) Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation 126: 314-324.
42. Jang YH, Kim JH, Ban C, Ahn K, Cheong JH, et al. (2012) Stromal Cell Derived Factor-1 (SDF-1) Targeting Reperfusion Reduces Myocardial Infarction in Isolated Rat Hearts. Cardiovascular therapeutics 30: 264-272.
43. House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, et al. (2003) Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation 108: 3140-3148.
44. Padin-Iruegas ME, Misao Y, Davis ME, Segers VF, Esposito G, Tokunou T, UrbanekK, Hosoda T, Rota M, Anversa P, Leri A, Lee RT, Kajstura J, (2009) Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improveendogenous and exogenous myocardial regeneration Circulation. Sep8 120(10): 876-87.
45. van der Velden JL, Schols AM, Willems J, Kelders MC, Langen RC, (2008) Glycogensynthase kinase 3 suppresses myogenic differentiation through negative regulationof NFATc3. The Journal of biological chemistry 283: 358-366.
46. van der Velden JL, Langen RC, Kelders MC, Wouters EF, Janssen-Heininger YM, (2006) etal (2006) Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation. American journal of physiology Cell physiology 290: C453-462.